The cerebral vasodilator response induced by topical nitroglycerin and nitroprusside was examined in cats equipped with cranial windows for the observation of the cerebral microcirculation. In cats subjected to chronic unilateral trigeminal ganglionectomy, the vasodilator responses to nitroprusside and nitroglycerin were markedly depressed on the denervated side. Application of a selective calcitonin gene-related peptide (CGRP) antagonist ] on the innervated side reduced the response to nitrodilators to the same extent as seen on the denervated side. The vasodilator response to acetylcholine was unaffected by trigeminal ganglionectomy. CGRP(8-37) almost abolished the vasodilator response to nitroglycerin and sodium nitroprusside and to CGRP, but did not affect the response to adenosine or to adenosine diphosphate. Pretreatment with LY83583, a drug that lowers cyclic GMP levels, diminished the vasodilation to CGRP and to nitroprusside but not to adenosine. We conclude that the nitrovasodilators activate sensory fibers to release CGRP, which in turn relaxes cerebral vascular smooth muscle by activating guanylate cyclase. Hence, nitrovasodilators possess a novel mechanism of action within the cephalic circulation which may explain both the occurrence of vasodilation and headache. 
T Nhe frequent occurrence of pain (headache) following nitrovasodilator administration suggests that nitrates activate trigeminovascular fibers.' Sensory nerve fibers innervate large and small pial blood vessels and project from nerve cells within the ipsilateral trigeminal ganglion.2 Destruction of this ganglion causes degeneration of neuropeptide-containing sensory fibers within the adventitial layer of cephalic blood vessels,45 and blockade of the hyperemia that accompanies reperfusion following global ischemia,6,7 severe acute hypertension, or seizures.8 9 Trigeminovascular fibers store and release calcitonin gene-related peptide,10"' a 37 amino acid-containing peptide and one of the most potent vasodilating substances,12 as well as substance P3,4 and neurokinin A.13 Superfusion with potassium, or the pungent chemical capsaicin, causes neuropeptide release from perivascular pial fibers by calcium-dependent mechanisms14 and CGRP release from the Langendorff heart preparation. 15 Electrical stimulation of sensory nerves innervating the meninges also releases CGRP into the venous effluent.16 Recep- tors for CGRP reside on vascular smooth muscle and mediate relaxation by cyclase-dependent mechanisms. '7'18 The competitive antagonist CGRP blocks CGRP-induced relaxation selectively and inhibits the increases in blood flow caused by electrical stimulation of splanchnic nerve fibers. 19 An important role for CGRP as a mediator of neurogenic vasodilation has thus been established.
In this study we examined the possibility that the nitrovasodilators nitroglycerin and/or sodium nitroprusside activate trigeminovascular fibers and by so doing, promote neuropeptide release and vasodilation within the pial vasculature. We also examined whether LY83583, a drug that lowers cyclic GMP, blocks the relaxation mediated by the topical application of the released neuropeptide CGRP or by sodium nitroprusside. We now report that nitrovasodilators activate perivascular sensory fibers directly, and by so doing, relax vascular smooth muscle via CGRP and cyclic GMP-dependent mechanisms within the cranial vasculature.
Materials and Methods

Preparation ofAnimals
Experiments were carried out in mongrel cats (2-4 kg) anesthetized with sodium pentobarbital (30 Results Figure 1 summarizes the responses of normal and denervated pial arterioles to the topical application of nitroglycerin, sodium nitroprusside, and acetylcholine. Sodium nitroprusside and nitroglycerin dilated small ( Figure 1A ) and large ( Figure 1B ) arterioles on the innervated side in a dose-dependent manner. With denervation, dilation was significantly less at each of the three tested doses. Small and large pial arterioles responded similarly. Acetylcholine (0.1 ,uM) relaxed vessels on the innervated and denervated hemispheres equally. Figure 2 demonstrates that the CGRP antagonist (1 ,uM) completely blocked nitroglycerin-induced vasodilation and markedly attenuated the response to sodium nitroprusside. Both small ( Figure 1A ) and large ( Figure  1B ) arterioles responded similarly. CGRP(8-37) (10 nM to 1 ,uM) alone did not change the diameter of large or small arterioles. Figure 2 also shows that CGRP-induced dilatation (0.01, 0.1 ,uM) was completely blocked by the CGRP antagonist but that the responses to ADP and adenosine were not (Figure 2) . Figure 3 shows that LY83583 significantly decreased the response to CGRP and nitroprusside at each of the tested doses. Nitroglycerin was not tested. By contrast, the response to adenosine (100 gM) was unaffected by the guanylate cyclase inhibitor. 
Discussion
The mechanism underlying relaxation of vascular smooth muscle by the nitrodilators nitroglycerin and sodium nitroprusside has been studied for the most part in large peripheral vessels in vitro such as the aorta, pulmonary artery, and vein (see Reference 21) . The classical view about their main mechanism of action is that they act directly on vascular smooth muscle to generate nitric oxide, either spontaneously The studies reported above show that feline cerebral arterioles possess a hitherto undescribed indirect mechanism underlying nitrovasodilator-induced vasodilation. The nitrovasodilators act on sensory fibers to release CGRP, which then diffuses to the vascular smooth muscle where it activates soluble guanylate cyclase to cause vasodilation. This appears to be their main mechanism of action on feline cerebral aterioles. The possibility that other vessels may utilize this mechanism merits further investigation especially in view of the likelihood that release mechanisms are difficult to demonstrate in sensory fibers using isolated blood vessel preparations. Our data also suggest that a secondary mechanism of relaxation is apparent, particularly at high doses of nitrodilators. CGRP(8-37) did not block a substantial portion of the vasodilation induced by highdose nitroprusside while it blocked completely the vasodilator action of CGRP in doses that induced vasodilation comparable with that caused by nitroprusside. The residual dilation may represent the direct action of the nitrodilators on vascular smooth muscle, although the finding that LY83583 had a much greater inhibitory effect on responses to CGRP than SNP (Figure 3) suggests a mechanism other than one dependent on guanylate cyclase activation.
The mechanism by which nitrodilators activate the release of vasodilator polypeptides from sensory fibers is not known. Several This work has been published previously in preliminary form.40
